|
|
||||||||
J Thorac Cardiovasc Surg 2004;128:170-179
© 2004 The American Association for Thoracic Surgery
Cardiopulmonary support and physiology |
a Division of Cardiothoracic Surgery, Department of Surgery, The University of Washington, Seattle, Wash, USA
b Department of Thoracic and Cardiovascular Surgery, Mie University, Tsu, Japan
Received for publication June 17, 2003; revisions received October 17, 2003; revisions received November 5, 2003; accepted for publication December 2, 2003.
* Address for reprints: Timothy H. Pohlman, MD, Department of Surgery, Division of Cardiothoracic Surgery, University of Washington, Box 356310, 1959 NE Pacific St, Seattle, WA 98195, USA
tpohlman{at}u.washington.edu
BACKGROUND: Restoration of blood flow to the ischemic heart may paradoxically exacerbate tissue injury (ischemia/reperfusion injury). Toll-like receptor 4, expressed on several cell types, including cardiomyocytes, is a mediator of the host inflammatory response to infection. Because ischemia/reperfusion injury is characterized by an acute inflammatory reaction, we investigated toll-like receptor 4 activation in a murine model of regional myocardial ischemia/reperfusion injury. We used C3H/HeJ mice, which express a nonfunctional toll-like receptor 4, to assess the pertinence of this receptor to tissue injury after reperfusion of ischemic myocardium.
METHODS: Wild-type mice (C3H/HeN) or toll-like receptor 4 mutant mice (C3H/HeJ) were subjected to 60 minutes of regional myocardial ischemia followed by 2 hours of reperfusion. At the end of reperfusion, the area at risk and the myocardial infarct size were measured as the end point of myocardial ischemia/reperfusion injury. Myocardial mitogen-activated protein kinase activation was measured by Western blotting, and nuclear translocation of nuclear factor-
B and activator protein-1 was determined by electrophoretic mobility shift assay. Ischemia/reperfusioninjured myocardium was also assessed by ribonuclease protection assay for expression of inflammatory mediators (tumor necrosis factor-
, interleukin-1ß, monocyte chemotactic factor-1, and interleukin-6).
RESULTS: The area at risk was similar for all groups after myocardial ischemia/reperfusion injury. There was a 40% reduction in infarct size (as a percentage of the area at risk) in C3H/HeJ mice compared with C3H/HeN mice (P = .001). Within the myocardium, significant activation of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase was observed in both strains after ischemia and during reperfusion as compared with an absence of mitogen-activated protein kinase activation during sham operations; however, c-Jun N-terminal kinase activity, but not p38 or extracellular signal-regulated kinase activity, was significantly reduced in C3H/HeJ mice (P < .05). In both groups, nuclear factor-
B and activator protein-1 nuclear translocation occurred in the myocardium during myocardial ischemia/reperfusion injury, but, by densitometric analysis, nuclear translocation of nuclear factor-
B and activator protein-1 was significantly decreased in C3H/HeJ mice compared with C3H/HeN mice. Interleukin-1ß, monocyte chemotactic factor-1, and interleukin-6 were detectable in reperfused ischemic myocardium but were not detected in sham-operated myocardium; the expression of each of these mediators was significantly decreased in the myocardial tissue of C3H/HeJ mice when compared with expression in the control C3H/HeN mouse strain.
CONCLUSIONS: Our data suggest that toll-like receptor 4 may mediate, at least in part, myocardial ischemia/reperfusion injury. Inhibition of toll-like receptor 4 activation may be a potential therapeutic target to attenuate ischemia/reperfusion-induced tissue damage in the clinical setting.
This article has been cited by other articles:
![]() |
J. Tian, X. Guo, X.-M. Liu, L. Liu, Q.-F. Weng, S.-J. Dong, A. A. Knowlton, W.-J. Yuan, and L. Lin Extracellular HSP60 induces inflammation through activating and up-regulating TLRs in cardiomyocytes Cardiovasc Res, June 1, 2013; 98(3): 391 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Lepper and R. Bals On the Edge: Targeting Toll-Like Receptor 2 in Ischemia/Reperfusion Injury Circ Cardiovasc Interv, April 1, 2012; 5(2): 146 - 149. [Full Text] [PDF] |
||||
![]() |
D. J. Marchant, J. H. Boyd, D. C. Lin, D. J. Granville, F. S. Garmaroudi, and B. M. McManus Inflammation in Myocardial Diseases Circ. Res., January 6, 2012; 110(1): 126 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, R. Si, Y. Feng, H. H. Chen, L. Zou, E. Wang, M. Zhang, H. S. Warren, D. E. Sosnovik, and W. Chao Myocardial Ischemia Activates an Injurious Innate Immune Signaling via Cardiac Heat Shock Protein 60 and Toll-like Receptor 4 J. Biol. Chem., September 9, 2011; 286(36): 31308 - 31319. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Mann The Emerging Role of Innate Immunity in the Heart and Vascular System: For Whom the Cell Tolls Circ. Res., April 29, 2011; 108(9): 1133 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Loukili, N. Rosenblatt-Velin, J. Li, S. Clerc, P. Pacher, F. Feihl, B. Waeber, and L. Liaudet Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo Cardiovasc Res, February 15, 2011; 89(3): 586 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Antoniak, M. Rojas, D. Spring, T. A. Bullard, E. D. Verrier, B. C. Blaxall, N. Mackman, and R. Pawlinski Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion Injury Arterioscler Thromb Vasc Biol, November 1, 2010; 30(11): 2136 - 2142. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Feng, L. Zou, R. Si, Y. Nagasaka, and W. Chao Bone marrow MyD88 signaling modulates neutrophil function and ischemic myocardial injury Am J Physiol Cell Physiol, October 1, 2010; 299(4): C760 - C769. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Schmid-Schonbein Toll-like receptor signaling mechanisms in hostile neutrophils. Focus on "Bone marrow MyD88 signaling modulates neutrophil function and ischemic myocardial injury" Am J Physiol Cell Physiol, October 1, 2010; 299(4): C731 - C732. [Full Text] [PDF] |
||||
![]() |
T. Ha, Y. Hu, L. Liu, C. Lu, J. R. McMullen, J. Kelley, R. L. Kao, D. L. Williams, X. Gao, and C. Li TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism Cardiovasc Res, September 1, 2010; 87(4): 694 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Dong, J. G. Vallejo, H.-P. Tzeng, J. A Thomas, and D. L. Mann Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways Am J Physiol Heart Circ Physiol, March 1, 2010; 298(3): H1079 - H1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cao, Y. Hu, W. Wu, T. Ha, J. Kelley, C. Deng, Q. Chen, C. Li, J. Li, and Y. Li The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury Cardiovasc Res, December 1, 2009; 84(3): 442 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Moses, L. Wagner, and S. D. Fleming TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage J. Leukoc. Biol., October 1, 2009; 86(4): 971 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ao, N. Zou, J. C. Cleveland Jr., D. A. Fullerton, and X. Meng Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70 Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H21 - H28. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Valen Extracardiac approaches to protecting the heart Eur J Cardiothorac Surg, April 1, 2009; 35(4): 651 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chao Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H1 - H12. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Feng, H. Zhao, X. Xu, E. S. Buys, M. J. Raher, J. C. Bopassa, H. Thibault, M. Scherrer-Crosbie, U. Schmidt, and W. Chao Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1311 - H1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cha, Z. Wang, L. Ao, N. Zou, C. A. Dinarello, A. Banerjee, D. A. Fullerton, and X. Meng Cytokines Link Toll-Like Receptor 4 Signaling to Cardiac Dysfunction After Global Myocardial Ischemia Ann. Thorac. Surg., May 1, 2008; 85(5): 1678 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. van der Kaaij and A. J.J.C. Bogers Invited Commentary Ann. Thorac. Surg., May 1, 2008; 85(5): 1685 - 1685. [Full Text] [PDF] |
||||
![]() |
H. Shao, Y. Shen, H. Liu, G. Dong, J. Qiang, and H. Jing Simvastatin Suppresses Lung Inflammatory Response in a Rat Cardiopulmonary Bypass Model Ann. Thorac. Surg., December 1, 2007; 84(6): 2011 - 2018. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hua, T. Ha, J. Ma, Y. Li, J. Kelley, X. Gao, I. W. Browder, R. L. Kao, D. L. Williams, and C. Li Protection against Myocardial Ischemia/Reperfusion Injury in TLR4-Deficient Mice Is Mediated through a Phosphoinositide 3-Kinase-Dependent Mechanism J. Immunol., June 1, 2007; 178(11): 7317 - 7324. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tsung, N. Zheng, G. Jeyabalan, K. Izuishi, J. R. Klune, D. A. Geller, M. T. Lotze, L. Lu, and T. R. Billiar Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury J. Leukoc. Biol., January 1, 2007; 81(1): 119 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shimamoto, T. H. Pohlman, S. Shomura, T. Tarukawa, M. Takao, and H. Shimpo Toll-Like Receptor 4 Mediates Lung Ischemia-Reperfusion Injury Ann. Thorac. Surg., December 1, 2006; 82(6): 2017 - 2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Stapel, S.-C. Kim, S. Osterkamp, P. Knuefermann, A. Hoeft, R. Meyer, C. Grohe, and G. Baumgarten Toll-like receptor 4 modulates myocardial ischaemia-reperfusion injury: Role of matrix metalloproteinases Eur J Heart Fail, November 1, 2006; 8(7): 665 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shimamoto, A. J. Chong, M. Yada, S. Shomura, H. Takayama, A. J. Fleisig, M. L. Agnew, C. R. Hampton, C. L. Rothnie, D. J. Spring, et al. Inhibition of Toll-like Receptor 4 With Eritoran Attenuates Myocardial Ischemia-Reperfusion Injury Circulation, July 4, 2006; 114(1_suppl): I-270 - I-274. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tsung, R. A. Hoffman, K. Izuishi, N. D. Critchlow, A. Nakao, M. H. Chan, M. T. Lotze, D. A. Geller, and T. R. Billiar Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells J. Immunol., December 1, 2005; 175(11): 7661 - 7668. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Maung, S. Fujimi, M. L. Miller, M. P. MacConmara, J. A. Mannick, and J. A. Lederer Enhanced TLR4 reactivity following injury is mediated by increased p38 activation J. Leukoc. Biol., August 1, 2005; 78(2): 565 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Liu, S. R. Krutzik, J. Kim, and R. L. Modlin Cutting Edge: All-trans Retinoic Acid Down-Regulates TLR2 Expression and Function J. Immunol., March 1, 2005; 174(5): 2467 - 2470. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |